Buscar alternativas:
"caso open" » "case open" (Expander búsqueda), "caso lopez" (Expander búsqueda), "cases open" (Expander búsqueda), "cado open" (Expander búsqueda), "caao open" (Expander búsqueda), "cao open" (Expander búsqueda)
"d_ opens" » "_ opens" (Expander búsqueda), "dea opens" (Expander búsqueda), "dna opens" (Expander búsqueda)
"o opens" » "_ opens" (Expander búsqueda), "1 opens" (Expander búsqueda), "2 opens" (Expander búsqueda)
"so open" » "do open" (Expander búsqueda), "ao open" (Expander búsqueda), "o open" (Expander búsqueda)
"esmo open" » "esto open" (Expander búsqueda), "eso open" (Expander búsqueda), "ecmo open" (Expander búsqueda)
Mostrando 1 - 20 Resultados de 1,294 Para Buscar '(((((("d_ opens") OR ("o opens"))) OR ("esmo open"))) OR ((("so open") OR ("caso open"))))', tiempo de consulta: 1.67s Limitar resultados
AIOM chooses ESMO Open—Cancer Horizons as its official journal: a warm welcome from ESMO Open
ESMO Open—Cancer Horizons and the future of oncology

CSCO joins ESMO Open—Cancer Horizons
ESMO Open: news in breast cancer 2019

ESMO Open welcomes the association with the Japanese Society of Medical Oncology (JSMO)
ESMO Open special series on new emerging targets in cancer immunotherapy

Announcing the ESMO Open special issue on upcoming molecular targets for cancer treatment
One year of ESMO Open: Cancer Horizons—where are we going from here?

Plasmodesmata. A Not So Open-and-Shut Case
Introducing a new ESMO Open article series: how I treat side effects of immunotherapy

Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion
First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion

CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open—Cancer Horizons pro and con discussion
EDUCAÇÃO A DISTÂNCIA: O CASO OPEN UNIVERSITY

New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an “ESMO Open – Cancer Horizons” Series
Erratum to ‘FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?’: [ESMO Open Volume 5, Issue 5, 2020, e000633]

En soutien aux personnels d’OpenEdition
Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088]

Study of induced current of 3D-open-shell-electrode detector
Corrigendum to ‘Clinical significance of ERBB2 exon 16 skipping: analysis of a real-world retrospective observational cohort study’: [ESMO Open Volume 5, Issue 6, 2020, e000985]

Herramientas de búsqueda: RSS — Enviar por Correo electrónico esta Búsqueda — Guardar Búsqueda